OneAquaHealth Project, published by OneAquaHealth Project. This guide is not an authorized publication; it is the continuous build for version 0.1.0-ci-build built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/oah/ and changes regularly. See the Directory of published versions

Table of Contents

0 Table of Contents

1 Home

2 Downloads

3 Logical Models

4 HealthIndicators Relationships

5 DataSet Relationships

6 IndicatorsOah Relationships

7 SimpleIndicator Relationships

8 StructuredIndicator Relationships

9 Sample Relationships

10 HealthMeasure Relationships

11 Artifacts Summary

11.1 Health Indicators

11.2 Health measure

11.3 OAH Data Set

11.4 OAH indicators

11.5 Sample

11.6 Simple Indicator

11.7 Structured Indicator

11.8 Group: OAH Cohort

11.9 Library: OAH Indicators

11.10 Location: OAH Indicators

11.11 Observation: OAH Health Measure

11.12 Observation: OAH Indicators

11.13 Observation: OAH Indicators with Components

11.14 Specimen: OAH Indicators

11.15 Library: number of records

11.16 Library: size

11.17 OAH Cohort Characteristic Code

11.18 OAH Health Indicators

11.19 OAH Indicators

11.20 OAH Indicators (Non-Health)

11.21 OAH Macrophytes Indicator Codes

11.22 OAH Macrophytes Indicator Codes (Non-Native)

11.23 OAH Macrophytes Indicator Values

11.24 OAH Observation Type with Components

11.25 OAH Riparian Vegetation Indicator Codes

11.26 OAH Riparian Vegetation Indicator Values

11.27 OAH Specimen Type

11.28 Temporary OAH Code System

11.29 OAH Simple Indicator Model to this guide Map

11.30 OAH Structured Indicator Model to this guide Map

11.31 OAH Data Set Model to this guide Map

11.32 OAH Data Set Model to this guide Map

11.33 OAH Data Set Model to this guide Map

11.34 OAH Indicators Model to this guide Map

11.35 OAH Sample Model to this guide Map

11.36 Device - HI98130 Pocket Tester

11.37 Group - Benevento disease prevalence (age 35-74)

11.38 Group - Benevento disease prevalence (all persons)

11.39 Group - Benevento disease prevalence (BN1 age 35-74)

11.40 Group - Benevento disease prevalence (BN1 all persons)

11.41 Group - Benevento disease prevalence (BN1 female age 35-74)

11.42 Group - Benevento disease prevalence (BN1 female)

11.43 Group - Benevento disease prevalence (BN1 male age 35-74)

11.44 Group - Benevento disease prevalence (BN1 male)

11.45 Group - Benevento disease prevalence (BN2 age 35-74)

11.46 Group - Benevento disease prevalence (BN2 all persons)

11.47 Group - Benevento disease prevalence (BN2 female age 35-74)

11.48 Group - Benevento disease prevalence (BN2 female)

11.49 Group - Benevento disease prevalence (BN2 male age 35-74)

11.50 Group - Benevento disease prevalence (BN2 male)

11.51 Group - Benevento disease prevalence (BN3 age 35-74)

11.52 Group - Benevento disease prevalence (BN3 all persons)

11.53 Group - Benevento disease prevalence (BN3 female age 35-74)

11.54 Group - Benevento disease prevalence (BN3 female)

11.55 Group - Benevento disease prevalence (BN3 male age 35-74)

11.56 Group - Benevento disease prevalence (BN3 male)

11.57 Group - Benevento disease prevalence (female age 35-74)

11.58 Group - Benevento disease prevalence (female)

11.59 Group - Benevento disease prevalence (male age 35-74)

11.60 Group - Benevento disease prevalence (male)

11.61 Group - Oslo disease prevalence (age 18-29)

11.62 Group - Oslo disease prevalence (age 30-39)

11.63 Group - Oslo disease prevalence (age 40-49)

11.64 Group - Oslo disease prevalence (age 50-59)

11.65 Group - Oslo disease prevalence (age 60-69)

11.66 Group - Oslo disease prevalence (age 70+)

11.67 Group - Oslo disease prevalence (all persons)

11.68 Group - Oslo disease prevalence (female age 18-29)

11.69 Group - Oslo disease prevalence (female age 30-39)

11.70 Group - Oslo disease prevalence (female age 40-49)

11.71 Group - Oslo disease prevalence (female age 50-59)

11.72 Group - Oslo disease prevalence (female age 60-69)

11.73 Group - Oslo disease prevalence (female age 70+)

11.74 Group - Oslo disease prevalence (female)

11.75 Group - Oslo disease prevalence (male age 18-29)

11.76 Group - Oslo disease prevalence (male age 30-39)

11.77 Group - Oslo disease prevalence (male age 40-49)

11.78 Group - Oslo disease prevalence (male age 50-59)

11.79 Group - Oslo disease prevalence (male age 60-69)

11.80 Group - Oslo disease prevalence (male age 70+)

11.81 Group - Oslo disease prevalence (male)

11.82 Library - Almyros comprehensive dataset

11.83 Library - Almyros indicator bundle

11.84 Library - Benevento comprehensive dataset

11.85 Library - Benevento site 01

11.86 Library - Benevento site 02

11.87 Library - Benevento site 03

11.88 Library - Benevento site 04

11.89 Library - Benevento site 05

11.90 Library - Benevento site 06

11.91 Library - Benevento site 07

11.92 Library - Benevento site 08

11.93 Library - Benevento site 09

11.94 Library - Benevento site 10

11.95 Library - Benevento site 11

11.96 Library - Benevento site 12

11.97 Library - Giofyros indicator bundle

11.98 Library - Oslo disease prevalence dataset

11.99 Location - Almyros Reach

11.100 Location - Almyros Stream

11.101 Location - Benevento (city)

11.102 Location - Benevento monitoring site 01

11.103 Location - Benevento monitoring site 02

11.104 Location - Benevento monitoring site 03

11.105 Location - Benevento monitoring site 04

11.106 Location - Benevento monitoring site 05

11.107 Location - Benevento monitoring site 06

11.108 Location - Benevento monitoring site 07

11.109 Location - Benevento monitoring site 08

11.110 Location - Benevento monitoring site 09

11.111 Location - Benevento monitoring site 10

11.112 Location - Benevento monitoring site 11

11.113 Location - Benevento monitoring site 12

11.114 Location - Giofyros Lower Reach

11.115 Location - Giofyros Reach A

11.116 Location - Giofyros River

11.117 Location - Nordre Aker (borough)

11.118 Observation - Almyros Aluminium dissolved (2013 summary)

11.119 Observation - Almyros Aluminium dissolved (2014 summary)

11.120 Observation - Almyros Aluminium dissolved (2018 summary)

11.121 Observation - Almyros Aluminium dissolved (2019 summary)

11.122 Observation - Almyros Aluminium dissolved (2020 summary)

11.123 Observation - Almyros Ammonium (2013 summary)

11.124 Observation - Almyros Ammonium (2014 summary)

11.125 Observation - Almyros Ammonium (2015 summary)

11.126 Observation - Almyros Ammonium (2018 summary)

11.127 Observation - Almyros Ammonium (2019 summary)

11.128 Observation - Almyros Ammonium (2020 summary)

11.129 Observation - Almyros Arsenic dissolved (2013 summary)

11.130 Observation - Almyros Arsenic dissolved (2014 summary)

11.131 Observation - Almyros Arsenic dissolved (2018 summary)

11.132 Observation - Almyros Arsenic dissolved (2019 summary)

11.133 Observation - Almyros Arsenic dissolved (2020 summary)

11.134 Observation - Almyros Cadmium dissolved (2013 summary)

11.135 Observation - Almyros Cadmium dissolved (2014 summary)

11.136 Observation - Almyros Cadmium dissolved (2018 summary)

11.137 Observation - Almyros Cadmium dissolved (2019 summary)

11.138 Observation - Almyros Cadmium dissolved (2020 summary)

11.139 Observation - Almyros Calcium (2018 summary)

11.140 Observation - Almyros Calcium (2019 summary)

11.141 Observation - Almyros Calcium (2020 summary)

11.142 Observation - Almyros Carbonates (2018 summary)

11.143 Observation - Almyros Carbonates (2019 summary)

11.144 Observation - Almyros Carbonates (2020 summary)

11.145 Observation - Almyros Chloride (2013 summary)

11.146 Observation - Almyros Chloride (2014 summary)

11.147 Observation - Almyros Chloride (2015 summary)

11.148 Observation - Almyros Chloride (2018 summary)

11.149 Observation - Almyros Chloride (2019 summary)

11.150 Observation - Almyros Chloride (2020 summary)

11.151 Observation - Almyros Chromium 6+ (2013 summary)

11.152 Observation - Almyros Chromium 6+ (2014 summary)

11.153 Observation - Almyros Chromium 6+ (2018 summary)

11.154 Observation - Almyros Chromium 6+ (2019 summary)

11.155 Observation - Almyros Chromium 6+ (2020 summary)

11.156 Observation - Almyros Chromium dissolved (2013 summary)

11.157 Observation - Almyros Chromium dissolved (2014 summary)

11.158 Observation - Almyros Chromium dissolved (2018 summary)

11.159 Observation - Almyros Chromium dissolved (2019 summary)

11.160 Observation - Almyros Copper dissolved (2013 summary)

11.161 Observation - Almyros Copper dissolved (2014 summary)

11.162 Observation - Almyros Copper dissolved (2018 summary)

11.163 Observation - Almyros Copper dissolved (2019 summary)

11.164 Observation - Almyros Copper dissolved (2020 summary)

11.165 Observation - Almyros Dissolved Oxygen (2013 summary)

11.166 Observation - Almyros Dissolved Oxygen (2014 summary)

11.167 Observation - Almyros Dissolved Oxygen (2015 summary)

11.168 Observation - Almyros Dissolved Oxygen (2018 summary)

11.169 Observation - Almyros Dissolved Oxygen (2019 summary)

11.170 Observation - Almyros Dissolved Oxygen (2020 summary)

11.171 Observation - Almyros Electrical conductivity (2013 summary)

11.172 Observation - Almyros Electrical conductivity (2014 summary)

11.173 Observation - Almyros Electrical conductivity (2015 summary)

11.174 Observation - Almyros Electrical conductivity (2018 summary)

11.175 Observation - Almyros Electrical conductivity (2019 summary)

11.176 Observation - Almyros Electrical conductivity (2020 summary)

11.177 Observation - Almyros electrical conductivity (2024-11-21)

11.178 Observation - Almyros electrical conductivity (2025-04-14)

11.179 Observation - Almyros Hydrogen carbonate (Bicarbonate) HCO3 (2018 summary)

11.180 Observation - Almyros Hydrogen carbonate (Bicarbonate) HCO3 (2019 summary)

11.181 Observation - Almyros Hydrogen carbonate (Bicarbonate) HCO3 (2020 summary)

11.182 Observation - Almyros Iron dissolved (2013 summary)

11.183 Observation - Almyros Iron dissolved (2014 summary)

11.184 Observation - Almyros Iron dissolved (2018 summary)

11.185 Observation - Almyros Iron dissolved (2019 summary)

11.186 Observation - Almyros Iron dissolved (2020 summary)

11.187 Observation - Almyros Lead dissolved (2013 summary)

11.188 Observation - Almyros Lead dissolved (2014 summary)

11.189 Observation - Almyros Lead dissolved (2018 summary)

11.190 Observation - Almyros Lead dissolved (2019 summary)

11.191 Observation - Almyros Lead dissolved (2020 summary)

11.192 Observation - Almyros Magnesium (2018 summary)

11.193 Observation - Almyros Magnesium (2019 summary)

11.194 Observation - Almyros Magnesium (2020 summary)

11.195 Observation - Almyros Manganese dissolved (2013 summary)

11.196 Observation - Almyros Manganese dissolved (2014 summary)

11.197 Observation - Almyros Manganese dissolved (2018 summary)

11.198 Observation - Almyros Manganese dissolved (2019 summary)

11.199 Observation - Almyros Manganese dissolved (2020 summary)

11.200 Observation - Almyros Mercury dissolved (2013 summary)

11.201 Observation - Almyros Mercury dissolved (2014 summary)

11.202 Observation - Almyros Mercury dissolved (2018 summary)

11.203 Observation - Almyros Mercury dissolved (2019 summary)

11.204 Observation - Almyros Mercury dissolved (2020 summary)

11.205 Observation - Almyros Nickel dissolved (2013 summary)

11.206 Observation - Almyros Nickel dissolved (2014 summary)

11.207 Observation - Almyros Nickel dissolved (2018 summary)

11.208 Observation - Almyros Nickel dissolved (2019 summary)

11.209 Observation - Almyros Nickel dissolved (2020 summary)

11.210 Observation - Almyros Nitrate (2013 summary)

11.211 Observation - Almyros Nitrate (2014 summary)

11.212 Observation - Almyros Nitrate (2015 summary)

11.213 Observation - Almyros Nitrate (2018 summary)

11.214 Observation - Almyros Nitrate (2019 summary)

11.215 Observation - Almyros Nitrate (2020 summary)

11.216 Observation - Almyros Nitrite (2013 summary)

11.217 Observation - Almyros Nitrite (2014 summary)

11.218 Observation - Almyros Nitrite (2015 summary)

11.219 Observation - Almyros Nitrite (2018 summary)

11.220 Observation - Almyros Nitrite (2019 summary)

11.221 Observation - Almyros Nitrite (2020 summary)

11.222 Observation - Almyros pH (2013 summary)

11.223 Observation - Almyros pH (2014 summary)

11.224 Observation - Almyros pH (2015 summary)

11.225 Observation - Almyros pH (2018 summary)

11.226 Observation - Almyros pH (2019 summary)

11.227 Observation - Almyros pH (2020 summary)

11.228 Observation - Almyros Potassium (2018 summary)

11.229 Observation - Almyros Potassium (2019 summary)

11.230 Observation - Almyros Potassium (2020 summary)

11.231 Observation - Almyros Sodium (2018 summary)

11.232 Observation - Almyros Sodium (2019 summary)

11.233 Observation - Almyros Sodium (2020 summary)

11.234 Observation - Almyros Sulphate (2013 summary)

11.235 Observation - Almyros Sulphate (2014 summary)

11.236 Observation - Almyros Sulphate (2015 summary)

11.237 Observation - Almyros Sulphate (2018 summary)

11.238 Observation - Almyros Sulphate (2019 summary)

11.239 Observation - Almyros Sulphate (2020 summary)

11.240 Observation - Almyros Temperature (water) (2013 summary)

11.241 Observation - Almyros Temperature (water) (2014 summary)

11.242 Observation - Almyros Temperature (water) (2015 summary)

11.243 Observation - Almyros Temperature (water) (2018 summary)

11.244 Observation - Almyros Temperature (water) (2019 summary)

11.245 Observation - Almyros Temperature (water) (2020 summary)

11.246 Observation - Almyros Total phosphates (2018 summary)

11.247 Observation - Almyros Total phosphates (2019 summary)

11.248 Observation - Almyros Total phosphates (2020 summary)

11.249 Observation - Almyros water temperature (2024-11-21)

11.250 Observation - Almyros water temperature (2025-04-14)

11.251 Observation - Almyros Zinc dissolved (2013 summary)

11.252 Observation - Almyros Zinc dissolved (2014 summary)

11.253 Observation - Benevento % of people affected from CVD (BN1 Female-Age-35-74)

11.254 Observation - Benevento % of people affected from CVD (BN1 Male-Age-35-74)

11.255 Observation - Benevento % of people affected from CVD (BN2 Female-Age-35-74)

11.256 Observation - Benevento % of people affected from CVD (BN2 Male-Age-35-74)

11.257 Observation - Benevento % of people affected from CVD (BN3 Female-Age-35-74)

11.258 Observation - Benevento % of people affected from CVD (BN3 Male-Age-35-74)

11.259 Observation - Benevento % of people affected from obesity (BN1 Female-Age-35-74)

11.260 Observation - Benevento % of people affected from obesity (BN1 Male-Age-35-74)

11.261 Observation - Benevento % of people affected from obesity (BN2 Female-Age-35-74)

11.262 Observation - Benevento % of people affected from obesity (BN2 Male-Age-35-74)

11.263 Observation - Benevento % of people affected from obesity (BN3 Female-Age-35-74)

11.264 Observation - Benevento % of people affected from obesity (BN3 Male-Age-35-74)

11.265 Observation - Benevento % of people under treatment for diabetes (BN1 Female-Age-35-74)

11.266 Observation - Benevento % of people under treatment for diabetes (BN1 Male-Age-35-74)

11.267 Observation - Benevento % of people under treatment for diabetes (BN2 Female-Age-35-74)

11.268 Observation - Benevento % of people under treatment for diabetes (BN2 Male-Age-35-74)

11.269 Observation - Benevento % of people under treatment for diabetes (BN3 Female-Age-35-74)

11.270 Observation - Benevento % of people under treatment for diabetes (BN3 Male-Age-35-74)

11.271 Observation - Benevento % of people under treatment for high blood pressure (BN1 Female-Age-35-74)

11.272 Observation - Benevento % of people under treatment for high blood pressure (BN1 Male-Age-35-74)

11.273 Observation - Benevento % of people under treatment for high blood pressure (BN2 Female-Age-35-74)

11.274 Observation - Benevento % of people under treatment for high blood pressure (BN2 Male-Age-35-74)

11.275 Observation - Benevento % of people under treatment for high blood pressure (BN3 Female-Age-35-74)

11.276 Observation - Benevento % of people under treatment for high blood pressure (BN3 Male-Age-35-74)

11.277 Observation - Benevento % of people under treatment for hypercholesterolemia (BN1 Female-Age-35-74)

11.278 Observation - Benevento % of people under treatment for hypercholesterolemia (BN1 Male-Age-35-74)

11.279 Observation - Benevento % of people under treatment for hypercholesterolemia (BN2 Female-Age-35-74)

11.280 Observation - Benevento % of people under treatment for hypercholesterolemia (BN2 Male-Age-35-74)

11.281 Observation - Benevento % of people under treatment for hypercholesterolemia (BN3 Female-Age-35-74)

11.282 Observation - Benevento % of people under treatment for hypercholesterolemia (BN3 Male-Age-35-74)

11.283 Observation - Benevento % of people under treatment for hypertension (BN1 Female-Age-35-74)

11.284 Observation - Benevento % of people under treatment for hypertension (BN1 Male-Age-35-74)

11.285 Observation - Benevento % of people under treatment for hypertension (BN2 Female-Age-35-74)

11.286 Observation - Benevento % of people under treatment for hypertension (BN2 Male-Age-35-74)

11.287 Observation - Benevento % of people under treatment for hypertension (BN3 Female-Age-35-74)

11.288 Observation - Benevento % of people under treatment for hypertension (BN3 Male-Age-35-74)

11.289 Observation - Benevento % of people with high blood pressure (prevalence) (BN1 Female-Age-35-74)

11.290 Observation - Benevento % of people with high blood pressure (prevalence) (BN1 Male-Age-35-74)

11.291 Observation - Benevento % of people with high blood pressure (prevalence) (BN2 Female-Age-35-74)

11.292 Observation - Benevento % of people with high blood pressure (prevalence) (BN2 Male-Age-35-74)

11.293 Observation - Benevento % of people with high blood pressure (prevalence) (BN3 Female-Age-35-74)

11.294 Observation - Benevento % of people with high blood pressure (prevalence) (BN3 Male-Age-35-74)

11.295 Observation - Benevento % of people with high blood sugar/diabetes (BN1 Female-Age-35-74)

11.296 Observation - Benevento % of people with high blood sugar/diabetes (BN1 Male-Age-35-74)

11.297 Observation - Benevento % of people with high blood sugar/diabetes (BN2 Female-Age-35-74)

11.298 Observation - Benevento % of people with high blood sugar/diabetes (BN2 Male-Age-35-74)

11.299 Observation - Benevento % of people with high blood sugar/diabetes (BN3 Female-Age-35-74)

11.300 Observation - Benevento % of people with high blood sugar/diabetes (BN3 Male-Age-35-74)

11.301 Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN1 Female-Age-35-74)

11.302 Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN1 Male-Age-35-74)

11.303 Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN2 Female-Age-35-74)

11.304 Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN2 Male-Age-35-74)

11.305 Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN3 Female-Age-35-74)

11.306 Observation - Benevento % of people with high total cholesterolemia (>=190 mg/dl) (BN3 Male-Age-35-74)

11.307 Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN1 Female-Age-35-74)

11.308 Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN1 Male-Age-35-74)

11.309 Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN2 Female-Age-35-74)

11.310 Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN2 Male-Age-35-74)

11.311 Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN3 Female-Age-35-74)

11.312 Observation - Benevento % of people with high total cholesterolemia (>=240 mg/dl) (BN3 Male-Age-35-74)

11.313 Observation - Benevento01 Benzene (2018 summary)

11.314 Observation - Benevento01 Benzene (2019 summary)

11.315 Observation - Benevento01 NO2 (2018 summary)

11.316 Observation - Benevento01 NO2 (2019 summary)

11.317 Observation - Benevento01 O3 (2018 summary)

11.318 Observation - Benevento01 O3 (2019 summary)

11.319 Observation - Benevento01 PM10 (2018 summary)

11.320 Observation - Benevento01 PM10 (2019 summary)

11.321 Observation - Benevento01 PM2.5 (2018 summary)

11.322 Observation - Benevento01 PM2.5 (2019 summary)

11.323 Observation - Benevento02 Benzene (2018 summary)

11.324 Observation - Benevento02 Benzene (2019 summary)

11.325 Observation - Benevento02 NO2 (2018 summary)

11.326 Observation - Benevento02 NO2 (2019 summary)

11.327 Observation - Benevento02 O3 (2018 summary)

11.328 Observation - Benevento02 O3 (2019 summary)

11.329 Observation - Benevento02 PM10 (2018 summary)

11.330 Observation - Benevento02 PM10 (2019 summary)

11.331 Observation - Benevento02 PM2.5 (2018 summary)

11.332 Observation - Benevento02 PM2.5 (2019 summary)

11.333 Observation - Benevento03 Benzene (2018 summary)

11.334 Observation - Benevento03 Benzene (2019 summary)

11.335 Observation - Benevento03 NO2 (2018 summary)

11.336 Observation - Benevento03 NO2 (2019 summary)

11.337 Observation - Benevento03 O3 (2018 summary)

11.338 Observation - Benevento03 O3 (2019 summary)

11.339 Observation - Benevento03 PM10 (2018 summary)

11.340 Observation - Benevento03 PM10 (2019 summary)

11.341 Observation - Benevento03 PM2.5 (2018 summary)

11.342 Observation - Benevento03 PM2.5 (2019 summary)

11.343 Observation - Benevento04 Benzene (2018 summary)

11.344 Observation - Benevento04 Benzene (2019 summary)

11.345 Observation - Benevento04 NO2 (2018 summary)

11.346 Observation - Benevento04 NO2 (2019 summary)

11.347 Observation - Benevento04 O3 (2018 summary)

11.348 Observation - Benevento04 O3 (2019 summary)

11.349 Observation - Benevento04 PM10 (2018 summary)

11.350 Observation - Benevento04 PM10 (2019 summary)

11.351 Observation - Benevento04 PM2.5 (2018 summary)

11.352 Observation - Benevento04 PM2.5 (2019 summary)

11.353 Observation - Benevento05 Benzene (2018 summary)

11.354 Observation - Benevento05 Benzene (2019 summary)

11.355 Observation - Benevento05 NO2 (2018 summary)

11.356 Observation - Benevento05 NO2 (2019 summary)

11.357 Observation - Benevento05 O3 (2018 summary)

11.358 Observation - Benevento05 O3 (2019 summary)

11.359 Observation - Benevento05 PM10 (2018 summary)

11.360 Observation - Benevento05 PM10 (2019 summary)

11.361 Observation - Benevento05 PM2.5 (2018 summary)

11.362 Observation - Benevento05 PM2.5 (2019 summary)

11.363 Observation - Benevento06 Benzene (2018 summary)

11.364 Observation - Benevento06 Benzene (2019 summary)

11.365 Observation - Benevento06 NO2 (2018 summary)

11.366 Observation - Benevento06 NO2 (2019 summary)

11.367 Observation - Benevento06 O3 (2018 summary)

11.368 Observation - Benevento06 O3 (2019 summary)

11.369 Observation - Benevento06 PM10 (2018 summary)

11.370 Observation - Benevento06 PM10 (2019 summary)

11.371 Observation - Benevento06 PM2.5 (2018 summary)

11.372 Observation - Benevento06 PM2.5 (2019 summary)

11.373 Observation - Benevento07 Benzene (2018 summary)

11.374 Observation - Benevento07 Benzene (2019 summary)

11.375 Observation - Benevento07 NO2 (2018 summary)

11.376 Observation - Benevento07 NO2 (2019 summary)

11.377 Observation - Benevento07 O3 (2018 summary)

11.378 Observation - Benevento07 O3 (2019 summary)

11.379 Observation - Benevento07 PM10 (2018 summary)

11.380 Observation - Benevento07 PM10 (2019 summary)

11.381 Observation - Benevento07 PM2.5 (2018 summary)

11.382 Observation - Benevento07 PM2.5 (2019 summary)

11.383 Observation - Benevento08 Benzene (2018 summary)

11.384 Observation - Benevento08 Benzene (2019 summary)

11.385 Observation - Benevento08 NO2 (2018 summary)

11.386 Observation - Benevento08 NO2 (2019 summary)

11.387 Observation - Benevento08 O3 (2018 summary)

11.388 Observation - Benevento08 O3 (2019 summary)

11.389 Observation - Benevento08 PM10 (2018 summary)

11.390 Observation - Benevento08 PM10 (2019 summary)

11.391 Observation - Benevento08 PM2.5 (2018 summary)

11.392 Observation - Benevento08 PM2.5 (2019 summary)

11.393 Observation - Benevento09 Benzene (2018 summary)

11.394 Observation - Benevento09 Benzene (2019 summary)

11.395 Observation - Benevento09 NO2 (2018 summary)

11.396 Observation - Benevento09 NO2 (2019 summary)

11.397 Observation - Benevento09 O3 (2018 summary)

11.398 Observation - Benevento09 O3 (2019 summary)

11.399 Observation - Benevento09 PM10 (2018 summary)

11.400 Observation - Benevento09 PM10 (2019 summary)

11.401 Observation - Benevento09 PM2.5 (2018 summary)

11.402 Observation - Benevento09 PM2.5 (2019 summary)

11.403 Observation - Benevento10 Benzene (2018 summary)

11.404 Observation - Benevento10 NO2 (2018 summary)

11.405 Observation - Benevento10 O3 (2018 summary)

11.406 Observation - Benevento10 PM10 (2018 summary)

11.407 Observation - Benevento10 PM2.5 (2018 summary)

11.408 Observation - Benevento11 NO2 (2018 summary)

11.409 Observation - Benevento11 O3 (2018 summary)

11.410 Observation - Benevento11 PM10 (2018 summary)

11.411 Observation - Benevento11 PM2.5 (2018 summary)

11.412 Observation - Benevento12 NO2 (2018 summary)

11.413 Observation - Benevento12 O3 (2018 summary)

11.414 Observation - Benevento12 PM10 (2018 summary)

11.415 Observation - Benevento12 PM2.5 (2018 summary)

11.416 Observation - Giofyros electrical conductivity (2024-11-21)

11.417 Observation - Giofyros electrical conductivity (2025-04-14)

11.418 Observation - Giofyros lower reach temperature (2024-11-21)

11.419 Observation - Giofyros lower reach temperature (2025-04-14)

11.420 Observation - Giofyros water temperature (2024-11-21)

11.421 Observation - Giofyros water temperature (2025-04-14)

11.422 Observation - Oslo % of people experience with mental health issues (Age-18-29)

11.423 Observation - Oslo % of people experience with mental health issues (Age-30-39)

11.424 Observation - Oslo % of people experience with mental health issues (Age-40-49)

11.425 Observation - Oslo % of people experience with mental health issues (Age-50-59)

11.426 Observation - Oslo % of people experience with mental health issues (Age-60-69)

11.427 Observation - Oslo % of people experience with mental health issues (Age-70-plus)

11.428 Observation - Oslo % of people experience with mental health issues (All)

11.429 Observation - Oslo % of people experience with mental health issues (Female)

11.430 Observation - Oslo % of people experience with mental health issues (Male)

11.431 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-18-29)

11.432 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-30-39)

11.433 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-40-49)

11.434 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-50-59)

11.435 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-60-69)

11.436 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Age-70-plus)

11.437 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (All)

11.438 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Female)

11.439 Observation - Oslo % of people that do not have Diabetes, COPD or Cardiovascular disease (Male)

11.440 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-18-29)

11.441 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-30-39)

11.442 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-40-49)

11.443 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-50-59)

11.444 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-60-69)

11.445 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Age-70-plus)

11.446 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (All)

11.447 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Female)

11.448 Observation - Oslo % of people that have or have had Diabetes, COPD or Cardiovascular disease (Male)

11.449 Observation - Oslo % of people with BMI 18,5-24,9 (Age-18-29)

11.450 Observation - Oslo % of people with BMI 18,5-24,9 (Age-30-39)

11.451 Observation - Oslo % of people with BMI 18,5-24,9 (Age-40-49)

11.452 Observation - Oslo % of people with BMI 18,5-24,9 (Age-50-59)

11.453 Observation - Oslo % of people with BMI 18,5-24,9 (Age-60-69)

11.454 Observation - Oslo % of people with BMI 18,5-24,9 (Age-70-plus)

11.455 Observation - Oslo % of people with BMI 18,5-24,9 (All)

11.456 Observation - Oslo % of people with BMI 18,5-24,9 (Female)

11.457 Observation - Oslo % of people with BMI 18,5-24,9 (Male)

11.458 Observation - Oslo % of people with BMI 25-29,9 (Age-18-29)

11.459 Observation - Oslo % of people with BMI 25-29,9 (Age-30-39)

11.460 Observation - Oslo % of people with BMI 25-29,9 (Age-40-49)

11.461 Observation - Oslo % of people with BMI 25-29,9 (Age-50-59)

11.462 Observation - Oslo % of people with BMI 25-29,9 (Age-60-69)

11.463 Observation - Oslo % of people with BMI 25-29,9 (Age-70-plus)

11.464 Observation - Oslo % of people with BMI 25-29,9 (All)

11.465 Observation - Oslo % of people with BMI 25-29,9 (Female)

11.466 Observation - Oslo % of people with BMI 25-29,9 (Male)

11.467 Observation - Oslo % of people with BMI <18,5 (Age-18-29)

11.468 Observation - Oslo % of people with BMI <18,5 (Age-30-39)

11.469 Observation - Oslo % of people with BMI <18,5 (Age-40-49)

11.470 Observation - Oslo % of people with BMI <18,5 (Age-50-59)

11.471 Observation - Oslo % of people with BMI <18,5 (Age-60-69)

11.472 Observation - Oslo % of people with BMI <18,5 (Age-70-plus)

11.473 Observation - Oslo % of people with BMI <18,5 (All)

11.474 Observation - Oslo % of people with BMI <18,5 (Female)

11.475 Observation - Oslo % of people with BMI <18,5 (Male)

11.476 Observation - Oslo % of people with BMI =>30 (Age-18-29)

11.477 Observation - Oslo % of people with BMI =>30 (Age-30-39)

11.478 Observation - Oslo % of people with BMI =>30 (Age-40-49)

11.479 Observation - Oslo % of people with BMI =>30 (Age-50-59)

11.480 Observation - Oslo % of people with BMI =>30 (Age-60-69)

11.481 Observation - Oslo % of people with BMI =>30 (Age-70-plus)

11.482 Observation - Oslo % of people with BMI =>30 (All)

11.483 Observation - Oslo % of people with BMI =>30 (Female)

11.484 Observation - Oslo % of people with BMI =>30 (Male)

11.485 Observation - Oslo % of people with long-term disease (Age-18-29)

11.486 Observation - Oslo % of people with long-term disease (Age-30-39)

11.487 Observation - Oslo % of people with long-term disease (Age-40-49)

11.488 Observation - Oslo % of people with long-term disease (Age-50-59)

11.489 Observation - Oslo % of people with long-term disease (Age-60-69)

11.490 Observation - Oslo % of people with long-term disease (Age-70-plus)

11.491 Observation - Oslo % of people with long-term disease (All)

11.492 Observation - Oslo % of people with long-term disease (Female)

11.493 Observation - Oslo % of people with long-term disease (Male)

11.494 Observation - Oslo % of people without long-term disease (Age-18-29)

11.495 Observation - Oslo % of people without long-term disease (Age-30-39)

11.496 Observation - Oslo % of people without long-term disease (Age-40-49)

11.497 Observation - Oslo % of people without long-term disease (Age-50-59)

11.498 Observation - Oslo % of people without long-term disease (Age-60-69)

11.499 Observation - Oslo % of people without long-term disease (Age-70-plus)

11.500 Observation - Oslo % of people without long-term disease (All)

11.501 Observation - Oslo % of people without long-term disease (Female)

11.502 Observation - Oslo % of people without long-term disease (Male)

11.503 Organization - ARPAC Campania